Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

F Ye, S Dewanjee, Y Li, NK Jha, ZS Chen, A Kumar… - Molecular cancer, 2023 - Springer
Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment

S Gao, X Yang, J Xu, N Qiu, G Zhai - ACS nano, 2021 - ACS Publications
Immunotherapy that harnesses the human immune system to fight cancer has received
widespread attention and become a mainstream strategy for cancer treatment. Cancer …

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation

H Li, Q Luo, H Zhang, X Ma, Z Gu, Q Gong… - Chemical Society …, 2023 - pubs.rsc.org
Cancer radio-immunotherapy, integrating external/internal radiation therapy with immuno-
oncology treatments, emerges in the current management of cancer. A growing number of …

Lipid anchor-mediated NK cell surface engineering for enhanced cancer immunotherapy

S Kim, S Li, M Gajendiran, AK Jangid, DJ Lee… - Chemical Engineering …, 2023 - Elsevier
Current natural killer (NK) cell-based cancer immunotherapy for the treatment of solid tumors
often exhibits insufficient cancer recognition specificity, thereby limiting therapeutic …

[HTML][HTML] Advanced hitchhiking nanomaterials for biomedical applications

Y Wang, SK Sun, Y Liu, Z Zhang - Theranostics, 2023 - ncbi.nlm.nih.gov
Hitchhiking, a recently developed bio-inspired cargo delivery system, has been harnessed
for diverse applications. By leveraging the interactions between nanoparticles and …

Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management

P Pandey, F Khan, N Alshammari, A Saeed… - Frontiers in …, 2023 - frontiersin.org
Garlic (Allium sativum L.) possesses numerous pharmacological potential, including
antibacterial, antiarthritic, antithrombotic, anticancer, hypoglycemic, and hypolipidemic …

Four ounces can move a thousand pounds: the enormous value of nanomaterials in tumor immunotherapy

Z Chen, Z Yue, K Yang, C Shen… - Advanced …, 2023 - Wiley Online Library
The application of nanomaterials in healthcare has emerged as a promising strategy due to
their unique structural diversity, surface properties, and compositional diversity. In particular …

Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview

A Javia, J Vanza, D Bardoliwala, S Ghosh… - International Journal of …, 2022 - Elsevier
Adagen, an enzyme replacement treatment for adenosine deaminase deficiency, was the
first protein-polymer conjugate to be approved in early 1990 s. Post this regulatory approval …

A Multiple Stimuli-Responsive NanoCRISPR Overcomes Tumor Redox Heterogeneity to Augment Photodynamic Therapy

J Yang, L Bai, M Shen, X Gou, Z Xiang, S Ma, Q Wu… - ACS …, 2023 - ACS Publications
Redox heterogeneity of tumor cells has become one of the key factors leading to the failure
of conventional photodynamic therapy (PDT). Exploration of a distinctive therapeutic strategy …

Nano-based theranostic platforms for breast cancer: a review of latest advancements

R Arshad, MH Kiani, A Rahdar, S Sargazi, M Barani… - Bioengineering, 2022 - mdpi.com
Breast cancer (BC) is a highly metastatic multifactorial disease with various histological and
molecular subtypes. Due to recent advancements, the mortality rate in BC has improved …